Dr. Konrad Stopsack is a molecular and clinical epidemiologist with a focus on cancer epidemiology and a background as a board-certified internal medicine physician. His main research interest is how potentially modifiable exposures cause solid tumors through genomic heterogeneity and influence cancer progression, and combining well-defined observational studies and state-of-the-art genomics in order to guide cancer prevention and treatment. His methodologic and teaching interests include application and further development of epidemiologic methods for high-dimensional biomarker studies and clinical studies. As a Senior Fellow Dr. Stopsack will focus on the development of cancer prevention and early detection curriculum.
